Has Kristin Schmidt, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $11,667 in general payments to Kristin Schmidt, APRN across 483 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristin Schmidt, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristin Schmidt, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristin Schmidt, APRN

Nurse Practitioner · Fleming Island, FLNPI 1578181210

Payments from drug & device makers

$11,667in general payments, 2019–2025

Across 483 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
AstraZeneca$879
Merck$845
Johnson & Johnson$576
Sanofi$384
Seagen Inc.$372
plus $7K from 54 others

What the payments were for

Consulting fees$1,35312%
Food & beverage$10,31588%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	38	$2,030
AstraZeneca(2 entities)	45	$879
Merck	36	$845
Johnson & Johnson(2 entities)	24	$576
Sanofi	20	$384
Seagen Inc.	20	$372
Eisai Inc.	16	$363
Daiichi Sankyo Inc.	20	$358
Pfizer	17	$344
Merz North America, Inc.	2	$320
Bayer	17	$299
GSK	14	$281
AbbVie(2 entities)	8	$271
Lilly USA, LLC	12	$262
Bristol Myers Squibb	13	$252
E.r. Squibb & Sons, L.L.C.	8	$250
Gilead	9	$198
Tersera Therapeutics LLC	8	$184
Incyte Corporation	10	$180
Takeda Pharmaceuticals U.S.A., Inc.	7	$176
Array Biopharma Inc	9	$163
Servier Pharmaceuticals LLC	9	$157
Astellas Pharma US Inc	9	$156
Taiho Oncology, Inc.	9	$153
Amgen	8	$150
Pharmacosmos Therapeutics Inc.	7	$144
Genentech USA, Inc.	7	$130
Regeneron Healthcare Solutions, Inc.	5	$114
Foundation Medicine, Inc.	1	$108
Jazz Pharmaceuticals Inc.	5	$103
Morphosys, US Inc.	5	$101
Stemline Therapeutics Inc.	4	$101
Beone Medicines USA, Inc.	4	$95
AVEO Pharmaceuticals, Inc.	5	$89
Sobi, Inc	3	$81
Puma Biotechnology, Inc.	5	$78
Agios Pharmaceuticals, Inc.	3	$68
Exelixis Inc.	3	$64
Revance Therapeutics, Inc.	1	$61
Genmab U.S., Inc.	2	$60
G1 Therapeutics, Inc.	3	$58
Pharmaessentia USA Corporation	2	$48
Ipsen Biopharmaceuticals, Inc	3	$46
Mirati Therapeutics, Inc.	2	$46
Sumitomo Pharma America, Inc.	3	$45
Iovance Biotherapeutics, Inc.	2	$43
Novocure Inc.	2	$39
Boehringer Ingelheim	2	$38
Abiomed	1	$34
Rigel Pharmaceuticals, Inc.	2	$33
Epizyme, Inc.	2	$29
CSL Behring	1	$29
Apellis Pharmaceuticals, Inc.	1	$27
Emmaus Medical, Inc.	1	$22
Azurity Pharmaceuticals, Inc.	1	$21
Blue Earth Diagnostics	1	$21
Immunocore Limited	1	$20
EMD Serono, Inc.	1	$19
Sun Pharmaceutical Industries Inc.	1	$15
Deciphera Pharmaceuticals Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,667 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024

$99,128

Medicare patients

Services billed

2,521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Betamethasone Dipropionate	11	$966
Ondansetron Hcl	11	$88

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Fleming Island

Jolanta BaginskiClearwater$494K
Adissa PerezWinter Park$370K
April WessonTampa$342K
Margarita FernandezMiami$311K
Stephanie SimmermanNaples$283K
Claudette WalkerPonte Vedra Beach$271K
Lisa NodzonTampa$246K
Ashima BahlTampa$226K
Maya BloombergMiami$202K
Jennifer PuleoTampa$171K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →